source
- Bicara appoints President Ryan Cohlhepp as CEO effective Jan. 1, while J&J veteran John Reed joins Madrigal boardBicara Therapeutics announced a leadership transition, naming its current President and COO Ryan Cohlhepp as the new chief executive officer effective Jan. 1. Cohlhepp will take over the role as t…
- MapLight presses the pause button; ADC Therapeutics considers what to do with Zynlonta⏸️ MapLight Therapeutics pauses preclinical and discovery work: The biotech said it will instead focus its resources on advancing its lead candidate, ML-007C-MA, for schizophrenia and Alzheimer’s d…Endpoints · 22m ago↗ source
- FDA grants accelerated approval to Bristol Myers' iberdomide for relapsed or refractory multiple myeloma